Brazil suspends Bharat Biotech's Covaxin clinical trials
The Hindu
The move comes after termination of the Hyderabad-based firm’s agreement with its partner.
Brazil has suspended the clinical studies of , Covaxin following termination of the company's agreement with its partner there, the South American Country's health regulator said. Bharat Biotech on Friday, July 23, 2021 announced cancellation of the for its COVID-19 vaccine Covaxin for the Brazilian market. The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.More Related News